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This study stresses the hypothesis whether hypoxic events contribute to formation and deposition of β-amyloid
(Aβ) in cerebral blood vessels by affecting the processing of endothelial amyloid precursor protein (APP).
Therefore, cerebral endothelial cells (ECs) derived from transgenic Tg2576 mouse brain, were subjected to
short periods of hypoxic stress, followed by assessment of formation and secretion of APP cleavage
products sAPPα, sAPPβ, and Aβ as well as the expression of endothelial APP. Hypoxic stress of EC leads to
enhanced secretion of sAPPβ into the culture medium as compared to normoxic controls, which is
accompanied by increased APP expression, induction of vascular endothelial growth factor (VEGF)
synthesis, nitric oxide production, and differential changes in endothelial p42/44 (ERK1/2) expression. The
hypoxia-mediated up-regulation of p42/44 at a particular time of incubation was accompanied by a
corresponding down-regulation of the phosphorylated form of p42/44. To reveal any role of hypoxia-
induced VEGF in endothelial APP processing, ECs were exposed by VEGF. VEGF hardly affected the
amount of sAPPβ and Aβ(1–40) secreted into the culture medium, whereas the suppression of the VEGF
receptor action by SU-5416 resulted in decreased release of sAPPβ and Aβ(1–40) in comparison to control
incubations, suggesting a role of VEGF in controlling the activity of γ-secretase, presumably via the VEGF
receptor-associated tyrosine kinase. The data suggest that hypoxic stress represents a mayor risk factor in
causing Aβ deposition in the brain vascular system by favoring the amyloidogenic route of endothelial APP
processing. The hypoxic-stress-induced changes in β-secretase activity are presumably mediated by
altering the phosphorylation status of p42/44, whereas the stress-induced up-regulation of VEGF appears to
play a counteracting role by maintaining the balance of physiological APP processing.
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Introduction
Alzheimer’s disease (AD), a heterogeneous and multi-
factorial disorder, is characterized clinically by demen-
tia and pathomorphologically by extracellular
accumulation of β-amyloid (Aβ) plaques and intra-
cellular tau-pathology. Aβ peptides are formed
through proteolytic processing of the amyloid precur-
sor protein (APP) by subsequent catalytic actions of
the β- and γ-secretase. Abnormal APP processing
has been assumed to play a causative role in AD devel-
opment resulting in an imbalance of production and
clearance of Aβ (amyloid cascade hypothesis of AD;
for reviews, see e.g.1–5), while the validity of the
amyloid hypothesis has also been questioned in
terms of its causality (for review, see e.g.6).
However, many AD cases also demonstrate cerebral
vascular changes and impaired regulation of cerebral
blood flow, that have been assumed to play an
important role in AD pathogenesis (vascular hypoth-
esis of AD, for review, see e.g.1,7–9). Insufficient cer-
ebral blood flow and hypoperfusion may induce
hypoxia-sensitive pathways leading to inflammation
with up-regulation of pro-inflammatory cytokines,
and to oxidative stress with generation of reactive
oxygen and nitrogen species which may be detrimental
to vascular integrity and function. Indeed, cerebrovas-
cular abnormalities such as thickening of the micro-
vascular basement membranes, decreased luminal
diameter, and microvascular degeneration, in particu-
lar in the temporal-parietal cortex, have frequently
been observed in AD patients.9
The cerebrovascular pathology includes the
accumulation of Aβ in blood vessels and microvascu-
lar degeneration (cerebral amyloid angiopathy) affect-
ing cerebral endothelium and vascular smooth muscle
cells.9–11 The cerebral amyloid angiopathy which is
observed during normal aging, and in the majority
of AD cases, is likely caused by the failure of Aβ elim-
ination from the brain parenchyma,12 while a role of
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vascular smooth muscle and endothelial cells (ECs) by
abnormal processing of APP has also been
suggested.13,14
There are a number of reports that ischemia and
hypoperfusion may trigger accumulation and cleavage
of APP into Aβ, and its deposition in the brain includ-
ing the vascular system (for reviews, see e.g.12,15), as
well as affecting Aβ degrading enzymes like neprilysin
and endothelin converting enzyme.16 The identifi-
cation of a functional hypoxia-responsive element in
the BACE1 gene promoter has disclosed a potential
mechanism by which hypoxia up-regulates β-secretase
cleavage of APP.17
On the other hand, the microvascular degenerations
observed in AD may also be the consequence of the
vasoactive detrimental effects of Aβ.18 Aβ is a potent
vasoconstrictor in the brain, as has been shown in
vivo and in vitro by application of exogenous Aβ to
normal blood vessels and to mouse cortex.19–23 On
the other hand, Aβ may cause degeneration of both
the larger perforating arterial vessels as well as cerebral
capillaries, presumably mediated through the induc-
tion of reactive oxygen species by activation of
NADPH oxidase, which may subsequently severely
affect regulation of cerebral blood vessels and brain
perfusion as well as impair the blood brain
barrier.11,24–26 Currently, in a transgenic AD mouse
model with strong cerebral amyloid angiopathy, a par-
ticular role of early perivascular astrocytic dysfunction
in impairing cerebrovascular and metabolic pathology
has been suggested.27
As vascular ECs are also capable to express and to
secrete APP,28 this study stresses the hypothesis
whether hypoxic events may contribute to formation
and deposition of Aβ in blood vessels by favoring
the amyloidogenic processing of endothelial APP. To
address this hypothesis, primary cerebral ECs
derived from transgenic Tg2576 mouse brain, were
subjected to short periods of hypoxic stress, followed
by assessment of formation and secretion of APP clea-
vage products such as sAPPα, sAPPβ, and Aβ as well
as the expression of endothelial APP.
Materials and methods
Preparation of primary cerebral endothelial cell
cultures
Primary cerebral microvascular ECs were isolated
from 2-month-old Tg2576 mouse brains according to
the method by Ichikawa et al.29
The Tg2576 mice contained as transgene the human
APP695 with the double mutation (K670N, M671L),
which was found in a large Swedish family with
early onset of AD, as developed and described pre-
viously by Hsiao et al.30 The transgeneity of the
pups was determined in tail tissue by polymerase
chain reaction.30
Culture solutions
Standard isolation medium (SIM) represents Ml99
containing 20 mM HEPES, 25 mM sodium bicarbon-
ate, penicillin streptomycin mixture (50 IU/ml, 50 μg/
ml), amphotericin B (2.5 μg/ml), heparin (10 U/ml),
and 5% FBS, and adjusted to a pH 7.4.
Growth medium-A (GM-A) represents DMEM
containing 20 mM sodium bicarbonate, 2 mM L-glu-
tamine, ECGF (150 μg/ml), penicillin–streptomycin
mixture (50 IU/ml, 50 μg/ml), amphotericin B
(2.5 μg/ml), MC-210 (0.5 μg/ml), heparin (10 U/
ml), and 20% FBS and adjusted to a pH 7.4.
Growth medium-B (GM-B) represents DMEM con-
taining 20 mM sodium bicarbonate, 2 mM L-gluta-
mine, penicillin–streptomycin mixture (50 IU/ml,
50 μg/ml), amphotericin B (2.5 μg/ml),
ECGF(150 μg/ml), 5% FBS, and 5% donor horse
serum and adjusted to a pH 7.4.
Freezing medium-A (FM-A) represents DMEM
containing 20 mM sodium bicarbonate, 2 mM L-glu-
tamine, penicillin–streptomycin mixture (50 IU/ml,
50 μg/ml), amphotericin B (2.5 μg/ml), heparin
(10 U/ml) and 20% FBS and adjusted to pH 7.4.
Freezing medium-B (FM-B) represents DMEM
containing 20 mM sodium bicarbonate, 2 mM L-glu-
tamine, penicillin–streptomycin mixture (50 I.U./ml,
50 μg/ml), amphotericin B (2.5 μg/ml), heparin
(10 U/ml), 20% dimethyl sulfoxide, and 40% FBS
and adjusted to a pH 7.4.
Isolation method
Ten 2-month-old Tg2576 mice were anesthetized by
CO2 inhalation, the brains were isolated, and cerebelli
and primary cerebral stems were removed. The
remaining primary cerebral tissue was placed into
70% ethanol, moved into ice-cold PBS (-) and then
rinsed five times in ice-cold SIM. The cerebral hemi-
spheres were carefully dissected out and finely
minced into small pieces, and then added with serum
free SIM (SFSIM). The suspension was centrifuged
at 1000 g, at 4°C for 10 minutes. The resulting pellet
was resuspended in 0.02% dispase solution (in
SFSIM) and incubated at 37°C for 60 minutes. The
dispase suspension was again centrifuged at 1000 g,
at 4°C for 10 minutes, and the pellet was resuspended
in 15% dextran solution (in SIM). After centrifugation
at 4500 g, 4°C for 10 minutes, the fat pad and dextran
solution were collected into a new tube and centri-
fuged once again. The two pellets were collected and
resuspended in the new dextran solution and centri-
fuged again. The resulting tissue pellet was resus-
pended in SFSIM and filtered through a 300-μm
mesh. The microvessel suspension was dissociated
using 0.1% collagenase/dispase (in SFSIM) at 37°C
for 30 minutes. After the enzyme treatment, the micro-
vessels were collected by centrifugation (1000 g, 4°C
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for 10 minutes), and resuspended in SIM. The suspen-
sion was layered onto Percoll gradient formed by cen-
trifugation of 50% isotonic Percoll at 25 000 g, at 4°C
for 70 minutes, and then centrifuged at 1650 g, at 4°C
for 10 minutes. After the Percoll gradient centrifu-
gation, three layers could be observed. The EC frag-
ments formed a band around the middle third of the
gradient, and the entire middle layer was collected
from gradients. The pellet was washed three times in
SIM. The preparation was resuspended in GM. The
cell suspension was seeded onto collagen-coated 35-
mm tissue culture dishes or 24-well tissue culture
plates at a density of 50 000 cells/cm2. The cells were
incubated in a moist 5% CO2, 95% air atmosphere,
at 37°C. After the cell attachment, the cells were main-
tained according to the method of Gordon et al.31
with minor modifications. For the first 3 days, the
cells were cultured in GM-A and then cultured in
GM-B after day 3. The culture medium was changed
every other day until the cells became a confluent
monolayer.
Freezing method for the isolated cells
The isolated cells (the pellets from the final centrifu-
gation) were resuspended in FM-A. Aliquots from
the cell suspension were placed in cryotubes at 4°C
and then an equal volume of FM-B was added to
each tube. The cryotubes were stored at −20°C for
24 hours and then moved to an ultrafreezer at
−80°C for up to 6 months. For cell culture, the
frozen cells were thawed in FM-A and washed three
times with GM-A.
The purity of EC cultures was checked by immunos-
taining with the rabbit anti-von Willebrandt factor
(Factor VIII-related antigen) antiserum (Sigma-
Aldrich, Munich, Germany, and the immunoperoxi-
dase method was used to visualize the signal.
Treatment of EC culture and tissue preparation
Following three to seven days of culture, the culture
medium was replaced by colorless stimulation
medium without serum containing the same com-
ponents like culture medium but supplemented with
4 mM L-glutamine.
For hypoxic stress experiments, the stimulation
medium was perfused by nitrogen gas for 30 minutes
to reduce the oxygen content in the medium, and
immediately used to replace the culture medium of
EC. Incubations of cells were continued in the pres-
ence of hypoxic colorless medium for up to 48 hours
as indicated. EC treated similarly but in the presence
of normal (normoxic) medium were considered as
control incubation.
For drug treatment experiments, EC were incubated
with 800 μl stimulation medium/well in the presence
of 1 ng/ml VEGF (R&D Systems, Germany) or
50 μM SU5416 (Biozol, Germany) for six, and 24
hours. Control incubations were treated similarly but
in the absence of any drug.
Following incubations, the culture medium was
carefully separated from the cell layer, centrifuged at
200 g for 10 minutes to remove cell debris. The super-
natant was stored at −20°C pending quantitation of
VEGF, sAPPβ, sAPPα, and β-amyloid present in the
medium.
Cells attached at the bottom of the well, were prop-
erly scraped off, homogenized by sonification in
400 μl/well of PBS, divided in aliquots, and stored at
−20°C. Aliquots of cell preparations were used for
Western blotting, and to assay the protein content as
described elsewhere.32
Assay of VEGF level
In select experiments, the constitutive secretion of
VEGF by primary EC into the medium was assayed
by enzyme-linked immunosorbent assay (ELISA)
applying a commercial kit, and was performed accord-
ing to the manufacturer’s protocol (R&D Systems,
Germany). The amount of VEGF was calculated by
comparison with a standard curve, and expressed as
pg/ml.33,34
To minimize falsifications of the data due to small
variations in cell number between wells and between
experimental sessions, VEGF values assayed in the
medium were referred to the protein content of the
particular cell homogenate measured at the end of
incubation.
Assay of APP cleavage products
sAPPα and sAPPβ
To quantitate the amount of human APP cleavage
products generated in EC and released into the
culture medium as a consequence of experimental
treatment, commercially available, solid phase sand-
wich ELISAs (IBL Hamburg, Germany) were
applied according to the manufacturer’s protocol.
The amounts of sAPPα, and sAPPβ were calculated
by comparison with a standard curve of recombinant
sAPPα, and sAPPβ, respectively, and expressed as
ng/ml.33,34
To minimize falsifications of the data due to small
variations in cell number between wells and between
experimental sessions, sAPPα and sAPPβ values
assayed in the medium were referred to the protein
content of the particular cell homogenate measured
at the end of incubation.
Assay of β-amyloid
The amount of human β-amyloid (Aβ) peptides
secreted into the cell culture medium during incu-
bation was analyzed using a sandwich ELISA system
for Aβ(1–40) commercially obtained from Invitrogen
(Darmstadt, Germany), and carried out according to
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the manufacturer’s protocol. The amount of Aβ(1–40)
was calculated by comparison with a standard curve of
synthetic human Aβ(1–40), and expressed as pg/
ml.33,34
To minimize falsifications of the data due to small
variations in cell number between wells and between
experimental sessions, Aβ(1–40) values assayed in the
medium were referred to the protein content of the
particular cell homogenate measured at the end of
incubation.
Western blot analysis to detect APP
Proteins of EC preparations were separated using stan-
dard sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE; 10% polyacrylamide-gel),
minigels (Miniprotean; Bio-Ra, Munich), sub-
sequently, transferred to a nitrocellulose-membrane
(Protean BA85, pore size 45 μm; Schleicher&Schüll)
using a Bio-Rad tankblot system. Membranes were
blocked for 60 minutes at room temperature with 4%
bovine serum albumin in Tris-buffered saline contain-
ing 0.1% Tween 20 (TBST) and incubated with the
primary antibodies over night at 4°C. The following
primary antibodies were applied: the monoclonal anti-
bodies anti-β-APP (22C11; Chemicon International,
1:2500) to detect APP, and the anti-mouse β-actin
(Sigma, Munich, Germany, 1:10 000) to be used as
internal standard. The blots were washed three times
for five minutes with (TBST). The secondary antibody
conjugated with horseradish peroxidase (goat-anti-
mouse) was incubated for 60 minutes at room temp-
erature, then washed three times with TBST. Protein
bands were visualized by enhanced chemiluminescence
detection (Western Blotting Luminol Reagent; Santa
Cruz Biotechnology, Heidelberg, Germany), accord-
ing to the manufacturer’s protocol.
Immunoblots were quantitatively evaluated by com-
puter-assisted densitometry using the software
package TINA (RAYTEST, Berlin). The optical
density level of each protein band of interest was nor-
malized to the corresponding expression level of β-
actin. Normalized APP expression data are expressed
as percentage of corresponding normoxic controls.34
Statistical analysis
All data were presented as mean± SEM. Statistical
comparison between experimental groups were tested
using one-way analysis of variance, followed by a
Student’s t-test analysis using SPSS software. P
values <0.05 were considered as statistically
significant.
Results
Hypoxic stress affects expression and
processing of APP
To reveal whether hypoxic stress affects the metab-
olism of APP, the cleavage products of APP such as
sAPPβ, sAPPα, and Aβ(1–40) released into the
medium of cultured EC were quantified by ELISA
after varying incubation times.
sAPPβ
Already in control incubations (normoxic conditions),
significant amounts of sAPPβ are released by EC, in
an incubation time-dependent manner (data not
shown). However, exposure of primary EC by
hypoxic stress resulted into considerably enhanced for-
mation and secretion of sAPPβ into the culture
medium as compared to corresponding values
assayed under normoxic control conditions (Fig. 1).
Already 6 hours after hypoxic stress of EC the
amount of sAPPβ released into the culture medium
was higher by about 80% (P< 0.01) as compared to
that detected under normoxic conditions. Following
an incubation period for up to 24 hours the amount
of sAPPβ detected in the culture medium was still
higher by 160% (P< 0.01) over control, with no
further increase till 48 hours of incubation (Fig. 1).
sAPPα
In control incubations (normoxic conditions), sAPPα
is released by ECs, in an incubation time-dependent
manner (not shown). However, hypoxic stress led to
Figure 1 Effect of hypoxic stress of primary EC on formation and secretion of sAPPβ, and sAPPα into the culture medium. The
ratio of corresponding amounts of sAPPβ and sAPPa is plotted against the incubation time. Data are expressed as x-fold of
control (= 1.0; incubations in normoxic condition), and represent the mean± SEM of six separate experiments. *P< 0.05 vs.
control, two-tailed Student’s t-test.
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enhanced generation and release of sAPPα into the
culture medium by about 100% (P< 0.05), already
detectable after a 6 hour-incubation period, with no
further increase for up to 48 hours of incubation
(Fig. 1).
Ratio of sAPPβ and sAPPα
To reveal whether hypoxic stress may shift the route of
APP processing toward the amyloidogenic one, the
ratio of the amount of sAPPβ and sAPPα released
into the culture medium is plotted versus incubation
time. As shown in Fig. 1 hypoxic stress drives the
endothelial APP processing toward the amyloidogenic
route.
APP expression
To disclose whether the hypoxic stress-induced
changes in endothelial APP processing are
accompanied by alterations in APP expression,
samples of cell homogenates of primary EC were sub-
jected to semiquantitative Western analysis for APP at
the end of the incubation period. Representative
examples of the immunoblots are shown in
Fig. 2A. Densitometric evaluation of the blots demon-
strated that hypoxic stress gradually increased the level
of APP expression with incubation time. Following 24
hours of incubation, the expression level of cellular
APP in hypoxia-stressed EC was significantly
increased by 88% (P< 0.05) as compared to cells incu-
bated under normal conditions (Fig. 2B).
Hypoxic stress induces VEGF up-regulation and
secretion into the culture medium
EC are known to respond to hypoxic, ischemic, or
hypoglycemic stress by up-regulation of VEGF. To
reveal whether the primary EC used in this study are
physiologically functional and are capable to
respond to hypoxic stress, the formation and secretion
of VEGF into the culture medium was assayed by
ELISA. Indeed, as shown in Fig. 3, after a delay of 4
hours post-hypoxia, ECs started to secrete VEGF
Figure 2 Effect of hypoxic stress on APP expression in primary EC with increasing incubation time. (A) Samples of cell
homogenates were subjected to SDS-PAGE, and APP was identified by western blotting using anti-APP monoclonal 22C11
antibody. β-actin was used as internal control to normalize APP expression data. (B) Results of densitometric analysis of
immunoblots for APP. Normalized APP expression is expressed as percentage change of corresponding normoxic controls and
represents the mean± SEM of six experiments. *P< 0.05 vs. control, two-tailed Student’s t-test.
Figure 3 Effect of hypoxic stress with increasing incubation
time on up-regulation and secretion of endothelial VEGF into
the culture medium. Data are expressed as percentage
change of control (= 100%; normoxia), and represent the
mean± SEM three separate experiments. *P< 0.05 vs.
control, two-tailed Student’s t-test.
Muche et al. Hypoxic stress, brain vascular system, and β-amyloid
Nutritional Neuroscience 2015 VOL. 18 NO. 1 5
into the culture medium. The amount of VEGF
released into the culture medium, strikingly increased
with further incubation, peaking at 24 hours and per-
sisting at this level for up to 48 hours post-hypoxia, as
compared to corresponding normoxic control
incubations.
Effect of VEGF on endothelial APP processing
In brain slices and primary neuronal cell cultures
VEGF has been shown to affect APP processing.33,34
Thus, the question arose whether the hypoxia-
induced up-regulation of VEGF is inducing and/or
mediating the changes of endothelial APP processing
following hypoxic stress.
Six hours after incubation of primary EC in the
presence of 1 ng/ml VEGF the amount of sAPPβ
assayed in the culture medium was lower by about
25% (P< 0.05), as compared to that detected in corre-
sponding control medium (Fig. 4). However, following
exposure of EC for up to 24 hours by VEGF the
amount of sAPPβ accumulated in the incubation
medium was no longer different to that detected in
culture medium of control incubations in the absence
of any drug (Fig. 4). Similarly, the exposure of EC
by VEGF for up to 24 hours did not affect the
amount of Aβ(1–40) secreted into the culture
medium in comparison to control incubations in the
absence of any drug (Fig. 4).
The effect of VEGF on APP processing is presum-
ably mediated through VEGF receptors which
mediate their actions through activation of the
VEGF receptor-associated tyrosine kinase.
To disclose whether the effect of VEGF is mediated
by VEGF receptor associated tyrosine kinase, primary
EC were incubated in the presence of the tyrosine
kinase inhibitor SU-5416 for various periods of time
followed by assessment of sAPPβ and Aβ(1–40) accu-
mulated in the culture medium.
Six hours after incubation of primary EC by 50 μM
SU-5416 the amount of sAPPβ assayed in the culture
medium was lower by about 24% (P< 0.05), as com-
pared to that detected in corresponding control
medium (Fig. 4). However, following exposure of EC
for up to 24 hours in the presence of SU-5416, the
amount of sAPPβ accumulated in the incubation
medium was no longer different to that detected in
culture media of control incubations in the absence
of any drug (Fig. 4). In contrast, treatment of EC
with SU-5416 for 6 hours resulted in decreased
secretion of Aβ(1–40) into the culture medium by
38% (P< 0.01), while further SU-5416 exposure of
EC for up to 24 hours led to even higher reduction
of Aβ(1–40) secretion into the culture medium (by
66%, P< 0.001; Fig. 4).
Effect of hypoxic stress on MAPK signaling in EC
The data obtained in chapter 3.3 provide evidence that
VEGF alone does not account for the hypoxia-
mediated effects on APP processing. Conversely,
VEGF appears to play a counteracting role by main-
taining a balanced APP processing.
On the other hand, MAPK signaling may also be
involved in the hypoxia-induced effects on APP clea-
vage. To disclose whether the changes in APP
expression and processing induced by hypoxic stress
are interrelated with intracellular MAPK signaling
cascades, cell homogenates of primary EC were sub-
jected to SDS-PAGE, blotted, and immunostained
for key enzymes of MAPK signaling cascades (p42/
44, p38, and JNK), including their phosphorylated
forms.
In Fig. 5A representative examples of western blots
from cell homogenates of EC are shown which were
Figure 4 Effect of exposure of endothelial cells by either 1 ng/ml VEGF or 50 μM SU-5416 on secretion of human sAPPβswe
and Aβ(1–40) into the culture medium analysed by commercial ELISA-Kits. Data are expressed as percentage change of control
(= 100%; incubations in the absence of VEGF or SU-5416), and represent the mean± SEM of five to six separate experiments.
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stained with antibodies against p42/44, phospho-p42/
44 (P-p42/44), JNK and phospho-JNK (P-JNK). The
expression of p38 could not be detected in the primary
EC preparations used in this study.
The results of the densitometric evaluation of the
immunoblots are graphed in Fig. 5B. For each
protein studied the expression level presented as
hypoxic stress-mediated up/down-regulation, is
plotted against the corresponding time of incubation
(Fig. 5B).
The densitometric evaluation of the immunoblots
revealed that the exposure of EC to hypoxic stress
affected neither the expression of phosphorylated
nor of non-phosphorylated forms of JNK as com-
pared to the corresponding normoxic controls,
regardless of the incubation time examined (data
not shown). In contrast, the expression of p42/44
and P-p42/44 were found to be differentially affected
when EC were subjected to hypoxic stress as
compared to corresponding control incubations
(Fig. 5B). When comparing the incubation-time
dependent expression pattern of p42/44 and P-p42/
44, opposing expression profiles over the incubation
time are observed: hypoxia-mediated up-regulation
of p42/44 at a particular time of incubation was
accompanied by a corresponding down-regulation of
P-p42/44 (Fig. 5B). During the first 4 hours of incu-
bation the expression of P-p42/44 was strikingly
up-regulated by 124% (P< 0.05), followed by down-
regulations by −25%, and −58% (P< 0.05) at 6
and 24 hours of incubation, respectively. In contrast,
the expression of p42/44 was down-regulated by
−7% at 4 hours of incubation, but slightly up-regu-
lated by about 20% (P< 0.05), and down-regulated
by −7% at 6, and 24 hours of incubation, respectively
(Fig. 5B).
Figure 5 (A) Representative examples of western blots of cell homogenates of primary endothelial cells whichwere stainedwith
antibodies against p42/44, phospho-p42/44 (P-p42/44), JNK and phospho-JNK (P-JNK). Data were normalized against β-actin
as internal protein control. B. Densitometric evaluation of immunoblots stained for p42/44 and P-p42/44 obtained from hypoxic-
stress-exposed EC preparations at the end of incubation times indicated. Data are expressed as a percentage change (up-/
down-regulation) of the corresponding normoxic controls and represent mean± SEM of three experiments. *P< 0.05 vs. control,
two-tailed Student’s t-test.
Muche et al. Hypoxic stress, brain vascular system, and β-amyloid
Nutritional Neuroscience 2015 VOL. 18 NO. 1 7
Discussion
The origin of the vascular amyloid deposits observed in
most cases of AD is still controversial, neuronal versus
vascular. To address this point, this study was under-
taken to disclose whether hypoxic stress may contribute
to the cerebral amyloid angiopathy10,13 by affecting
endothelial APP processing. Therefore, primary cer-
ebral EC derived from transgenic Tg2576 mouse
brain, were subjected to short periods of hypoxic
stress, followed by assessment of formation and
secretion of APP cleavage products such as sAPPα,
sAPPβ, and Aβ. The main finding of this study is that
hypoxic stress changes the ratio of α-, and β-secretory
processing of endothelial APP by favoring the amyloi-
dogenic route of APP metabolism, which is
accompanied by induction of VEGF, generation of
NO, and changes in p42/44 (ERK1/2) expression.
The primary ECs used in this study were obtained
from brain tissue of 2-month-old transgenic Tg2576
mice. The Tg2576 mouse brain demonstrates about a
six-fold higher expression of the human APP trans-
gene as compared to the endogenous murine APP,30
which makes assessments of APP cleavage products
more accessible, and allows to exploit the greater avail-
ability of antibodies directed against human APP clea-
vage products.
The purity of the isolated EC was checked by sub-
jecting sample preparations to immunocytochemistry
using an antiserum directed against the Von-
Willebrandt Factor (Factor VIII-related antigen), a
reliable marker for EC. Cross-checking revealed that
the primary EC cultures used for the experiments did
not contain significant amounts of neurons and/or
astrocytes. The ECs responded to hypoxic stress by
up-regulation of VEGF and production of reactive
nitrogen species indicating their viability and proper
physiological function.
Incubation of EC under normoxic conditions (con-
trols) for up to 24 hours resulted already in an incu-
bation time-dependent accumulation of sAPPα,
sAPPβ and Aβ peptides in the culture medium. The
release of APP cleavage products by EC indicates a
continuing proteolytic processing of cellular APP.
The ratio of the amount of sAPPα and sAPPβ released
into the culture medium under normoxic condition
accounts for about 0.8, suggesting that both α- and
β-secretory processing of endothelial APP occurs at
the same extent. However, when ECs were subjected
to hypoxic stress, the processing of endothelial APP
is shifted toward the amyloidogenic route of APP clea-
vage, which may be due to (i) changes in enzyme
activities of α- and/or β-secretases, and/or (ii)
changes in the expression level of endothelial APP.
Hypoxic stress of EC for up to 48 hours of incu-
bation resulted in enhanced generation and release of
sAPPβ, as compared to corresponding control incu-
bations, whereas the amount of sAPPα released into
the culture medium did not change with incubation
time, suggesting that hypoxic stress appears to predo-
minantly affect the activity of the β-secretase, with
presumably no consequences on the activity of the α-
secretase. Similarly, incubation of SH-SY5Y cells
under hypoxic conditions also affected APP proces-
sing but a reduced secretion of sAPPα into the
culture medium has been observed.35,36 Interestingly,
similar observations have also been obtained by in
vivo studies demonstrating that hypoxia affects APP
metabolism by increasing expression and activity of
BACE-1 and γ-secretase.17,37,38
On the other hand, hypoxic stress also induced the
synthesis of new endothelial APP as revealed by
Western analysis, which may explain the initial
increase of both sAPPα and sAPPβ level in the
culture medium of exposed EC. However, further
exposure of hypoxic-stressed EC for up to 48 hours
clearly indicates that the β-secretory route of APP pro-
cessing dominates the α-secretory one. As the regu-
lation of expression and synthesis of APP is highly
complex and involves transcriptional, post-transcrip-
tional, translational, and post-translational events
including the action of regulatory RNA-binding pro-
teins (for review, see39), more detailed investigations
are required to disclose how hypoxic events may inter-
fere with these molecular processes.
Regardless of that the question arises which factors
and/or processes may contribute to the hypoxic stress-
mediated induction of enhanced β-secretase activity in
EC. Recently, we have shown in brain slices and
primary neuronal cell cultures that VEGF may affect
neuronal APP processing.33,34 As VEGF was found
to be up-regulated in EC by hypoxic stress, it was inter-
esting to clarify whether VEGF plays also a role in
controlling endothelial APP processing. While
exposure of EC by VEGF hardly affected the
amount of sAPPβ and Aβ(1–40) generated and
secreted into the culture medium, the suppression of
the VEGF receptor action by the VEGF receptor
inhibitor SU-5416 resulted in decreased release of
sAPPβ and Aβ(1–40), as compared to control incu-
bations. These observations suggest that the hypoxic
stress-mediated up-regulation of VEGF hardly con-
tributes to the hypoxic stress-mediated changes in
endothelial APP processing, but rather playing a coun-
teracting role by maintaining a balanced APP proces-
sing. Moreover, the decreases in formation and
secretion of Aβ(1–40) by suppression of the VEGF
receptor action, suggest a role of VEGF in controlling
the activity of γ-secretase via VEGF receptors, pre-
sumably via the VEGF receptor-associated tyrosine
kinases. This suggestion is supported by a recent
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study demonstrating that both receptor- and non-
receptor tyrosine kinases may induce the cleavage of
APP using an in vitro system based on the APP-
Gal4-fusion protein stably transfected in SH-SY5Y
neuroblastoma cell line.40 However, the regulation of
the γ-secretase, a multiprotein complex consisting of
at least four distinct entities appears to be very
complex, even due to the abundance of interacting
partners and diversity of substrates.41,42
Hypoxic stress of EC also induced generation and
secretion of nitric oxide (NO) which is certainly
mediated by induction of the hypoxia-inducible
factor (HIF)-1α transcription factor that subsequently
may up-regulate iNOS expression followed by NO
production.43 HIF-1α, up-regulated in response to
low level of cellular oxygen, is also known to increase
BACE1 mRNA and protein level, which may provide
one of the molecular mechanism by which hypoxic
stress affects endothelial APP processing observed in
this study.38,44,45 On the other hand, a recent micro-
dialysis study in rats reported a direct involvement of
NO in up-regulation of hippocampal BACE1
expression and Aβ production following an acute
ischemic episode.46 The developmental temporal
coincidence of increased levels of NO and reactive
nitrogen species with the onset of Aβ plaque depo-
sition in Tg2576 mice further suggests a role of NO
in triggering expression and activity of β-secretase.47
However, it remains to be elucidated whether the
hypoxic stress-mediated increase in endothelial
sAPPβ production represents a consequence of stress-
induced NO formation.
Expression and activity of α- and β-secretases can be
regulated on different levels of cell physiology such as
transcription, translation, and post-translation,48–51
while the molecular mechanisms controlling α- and
β-secretase-cleavage of APP are not fully understood
yet. However, signal molecules such as NO or
VEGF may play a role in affecting those signaling
pathways that mediate secretase activity beyond tran-
scriptional and translational control, e.g. G-protein
coupled receptor-, MAPK-, and tyrosine kinase
signaling.
Hypoxic stress of EC resulted also in differential
expression of p42/44 and P-p42/44 over the incu-
bation time studied. Hypoxia-mediated up-regulation
of p42/44 at a particular time of incubation was
accompanied by a corresponding down-regulation of
P-p42/44 suggesting the involvement of MAPK sig-
naling in control and/or regulation of secretases.
Indeed, there are a number of studies reporting links
of MAPK signaling and expression and activity of
both α- and β-secretases. In primary murine cortical
neurons an up-regulation of the α-secretases
(ADAM10) by activation of NMDA receptors via
Wnt/MAPK signaling has been observed.52 Another
study in APPswe-transfected SH-SY5Y cells suggested
a link of α-secretase activity and ERK signaling.53 In
PC12 cells, it was reported that the insulin-like
growth factor 1-induced reduction of BACE1
expression might involve the MAPK/ERK1/2 signal-
ing.54 The activation of the ERK pathways induced
the inhibition of α-, and γ-secretase activity,55,56 as
well as acts as negative modulator of BACE1
expression and activity.57 Studies in SH-SY5Y cells
suggested that formation of sAPPα and BACE1
expression are regulated by muscarinic acetylcholine
receptors via ERK1/2.58,59
These experimental data fit very well with reports of
changes in total ERK1/2 level observed in brain
samples from AD patients as compared to healthy
control subjects,60–62 further supporting the important
role of MAPK signaling in the pathogenesis of AD.
It is interesting to note that the hypoxic stress-
mediated increase in formation and release of sAPPβ
is accompanied by corresponding down-regulation of
P-p42/44 expression. In Fig. 6 we have tentatively
plotted the hypoxic stress-mediated increase in
sAPPβ generation against the corresponding change
in P-p42/44 expression, indicating a negative corre-
lation of sAPPβ formation and P-p42/44 expression.
These observations suggest that the activity of the β-
secretase may be controlled and/or regulated by phos-
phorylation of p42/44.
Surprisingly, the exposure of EC to hypoxic stress
affected neither the expression of phosphorylated nor
of non-phosphorylated forms of JNK as compared
to the corresponding normoxic controls, regardless
of the incubation time examined. In contrast, 4-hydro-
xynonenal, an oxidative stress mediator has been
observed to up-regulate BACE1 through the activation
of JNK and p38-MAPK signaling,51 suggesting
Figure 6 Correlation of hypoxic stress-mediated changes of
sAPPβ and up-/down-regulation of p42/44 and P-p42/44
versus incubation time.
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differential cellular mechanisms by which expression
and activity of the β-secretase is driven.
In conclusion, the data presented in this study
strongly suggest that hypoxic stress represents a
mayor risk factor in mediating cerebral vascular Aβ
accumulation by shifting the ratio of α- and β-secretory
processing of endothelial APP toward the amyloido-
genic route of APP metabolism. The enhancement of
β-secretase activity as a consequence of hypoxic
stress is presumably mediated by changing the phos-
phorylation status of the p42/44 MAPK, whereas
the stress-induced up-regulation of VEGF appears to
play a counteracting role by maintaining a balanced
APP processing.
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